Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6420
    -0.0006 (-0.09%)
     
  • OIL

    83.25
    +0.52 (+0.63%)
     
  • GOLD

    2,402.90
    +4.90 (+0.20%)
     
  • Bitcoin AUD

    99,910.00
    +1,020.46 (+1.03%)
     
  • CMC Crypto 200

    1,379.99
    +67.37 (+5.13%)
     
  • AUD/EUR

    0.6021
    -0.0010 (-0.16%)
     
  • AUD/NZD

    1.0899
    +0.0024 (+0.22%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,037.65
    -356.67 (-2.05%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,986.40
    +211.02 (+0.56%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Trocars Global Market Report 2021: COVID-19 Growth And Change

Major players in the trocars market are Johnson & Johnson Medical Devices, B. Braun Melsungen AG, Medtronic, Teleflex Incorporated, CooperSurgical Inc. , CONMED Corporation, Applied Medical Resources Corporation, LaproSurge, Purple Surgical, Unimax medical systems Inc, and Olympus Corporation.

New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Trocars Global Market Report 2021: COVID-19 Growth And Change" - https://www.reportlinker.com/p06152587/?utm_source=GNW


The global trocars market is expected to grow from $642.8 million in 2020 to $686.7 million in 2021 at a compound annual growth rate (CAGR) of 6.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $949.8 million in 2025 at a CAGR of 8.4%.

The trocars market consists of sales of trocars by entities (organizations, sole traders, and partnerships) that manufacture trocars.A trocar is a medical or veterinary device made up of an awl, a cannula, and a seal.

Trocars are sharp-pointed surgical devices that puncture a bodily cavity and offer intra-abdominal access when used with a cannula. It is a type of instrument used in surgeries to insert various surgical implements into blood vessels and to allow the escape of gas and fluid from body organs.

The main types of products in trocars are disposable trocars, reposable trocars, reusable trocars, and accessories.The disposable trocars can be used only once which is for single use and then discarded.

Disposable trocars typically have valve designs that enable instrumentation to pass through easily and safety mechanisms that minimize the likelihood of visceral injury from the trocar point. The different types of tip include bladeless trocars, optical trocars, bladed trocars, blunt trocars and are used in general surgery, gynecological surgery, urological surgery, bariatric surgery, others.

North America was the largest region in the trocars market in 2020.Europe was the second-largest region the in trocars market.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The growing technological advancements are shaping the trocars market.The companies in the market are increasingly investing in improving the technology of trocars, which reduces the scope of error and makes the procedure better.

For instance, in March 2019, Fujifilm, a Japan-based provider of minimally invasive surgical solutions launched Fujifilm InterLock Trocar based on Chip-on-Tip technology. The Fujifilm InterLock trocar is a new tandem motion visualization device that allows a surgeon to simultaneously handle a laparoscope and a hand instrument with one hand.

In March 2021, Vernacare, UK-based infection prevention, and hygiene product manufacturer acquired Robinson Healthcare for an undisclosed amount. The acquisition continues Vernacare’s buy and build strategy and increases the Group’s turnover to $167.5 million (£120m) annually. Robinson Healthcare is a UK-based company that manufactures single-use surgical instruments such as trocars, injection-molded single-use sterile devices, and steel-polymer composite devices.

The increasing aging population is expected to increase the prevalence of age-related ailments thus contributing to the growth of the trocars market over coming years.The elderly population is increasing rapidly across the world and it is expected to continue over the forecast period.

Several routine surgical procedures are being gradually replaced by laparoscopic techniques in the older population.During laparoscopic surgery, trocars are inserted through the abdomen to cause minimal invasion to a patient.

According to the World Population Ageing Report, in 2019, the world’s population of people aged 65 and up was 703 million, with the number of people aged 65 and up expected to double to 1.5 billion by 2050. Therefore, the increasing aging population drives the growth of the trocars market.

The countries covered in the trocars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Read the full report: https://www.reportlinker.com/p06152587/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001